2011
DOI: 10.1016/j.jspi.2011.01.006
|View full text |Cite
|
Sign up to set email alerts
|

A new response-adaptive design for continuous treatment responses for phase III clinical trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…They 25 also provided a self-weighted version, where α is determined sequentially depending on the current proportional treatment imbalance together with the results of a detailed simulation for responses without any finite moments. Along the same line of thinking, the authors provided a variation of the above allocation 26 in a very recent work by replacing P (| X 11 − X 12 | > | X 21 − X 22 |) by P ( X 11 2 > X 21 2 ) . …”
Section: General Allocation Designsmentioning
confidence: 99%
See 1 more Smart Citation
“…They 25 also provided a self-weighted version, where α is determined sequentially depending on the current proportional treatment imbalance together with the results of a detailed simulation for responses without any finite moments. Along the same line of thinking, the authors provided a variation of the above allocation 26 in a very recent work by replacing P (| X 11 − X 12 | > | X 21 − X 22 |) by P ( X 11 2 > X 21 2 ) . …”
Section: General Allocation Designsmentioning
confidence: 99%
“…This can also be treated as a continuous variable. 2426 Time to event outcome is of interest in some situations. For example, Fu et al.…”
Section: Introductionmentioning
confidence: 99%